Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 3/2016

01-09-2016 | Viewpoint

Statin reduces orbitopathy risk in patients with Graves’ disease by modulating apoptosis and autophagy activities

Authors: Maurizio Bifulco, Elena Ciaglia

Published in: Endocrine | Issue 3/2016

Login to get access

Abstract

Statins use has been associated with reduced risk for developing orbitopathy among patients with Graves’ disease. We hypothesize that statin reduces orbitopathy risk mainly by modulating both apoptosis and autophagy activities in patients with Graves’ disease.
Literature
1.
J.M. Hershman, Statins and thyroidectomy may reduce the risk of orbitopathy developing in patients with Graves’ disease. Clin. Thyroidol. 27, 32–33 (2015)CrossRef
2.
J.D. Stein, D. Childers, S. Gupta, N. Talwar, B. Nan, B.J. Lee, T.J. Smith, R. Douglas, Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease. JAMA Ophthalmol. 133, 290–296 (2015)CrossRefPubMedPubMedCentral
3.
A. Kawashima, K. Tanigawa, T. Akama, A. Yoshihara, N. Ishii, K. Suzuki, Innate immune activation and thyroid autoimmunity. J. Clin. Endocrinol. Metab. 96, 3661–3671 (2011)CrossRefPubMed
4.
J.S. Yoon, H.J. Lee, M.K. Chae, E.J. Lee, Autophagy is involved in the initiation and progression of Graves’ orbitopathy. Thyroid 25, 445–454 (2015)CrossRefPubMed
5.
M.C. Maiuri, E. Zalckvar, A. Kimchi, G. Kroemer, Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 8(9), 741–752 (2007)CrossRefPubMed
6.
O. Konuk, A. Hondur, N. Akyurek, M. Unal, Apoptosis in orbital fibroadipose tissue and its association with clinical features in Graves’ ophthalmopathy. Ocular Immunol. Inflamm. 15, 105–111 (2007)CrossRef
7.
M. Thurnher, O. Nussbaumer, G. Gruenbacher, Novel aspects of mevalonate pathway inhibitors as antitumor agents. Clin. Cancer Res. 18(13), 3524–3531 (2012)CrossRefPubMed
8.
S. Ghavami, B. Yeganeh, G.L. Stelmack, H.H. Kashani, P. Sharma, R. Cunnington, S. Rattan, K. Bathe, T. Klonisch, I.M. Dixon, D.H. Freed, A.J. Halayko, Apoptosis, autophagy and ER stress in mevalonate cascade inhibition-induced cell death of human atrial fibroblasts. Cell Death Dis. 3, e330 (2012)CrossRefPubMedPubMedCentral
9.
M.J. Shih, S.L. Liao, K.T. Kuo, T.J. Smith, L.M. Chuang, Molecular pathology of Muller’s muscle in Graves’ ophthalmopathy. J. Clin. Endocrinol. Metab. 91(3), 1159–1167 (2006)CrossRefPubMed
10.
V. Croons, I. De Meyer, S.M. Houten, W. Martinet, H. Bult, A.G. Herman, G.R. De Meyer, Effect of statins on the viability of macrophages and smooth muscle cells. J. Cardiovasc. Pharmacol. 55(3), 269–275 (2010)CrossRefPubMed
11.
E.H. Lai, C.Y. Hong, S.H. Kok, K.L. Hou, L.H. Chao, L.D. Lin, M.H. Chen, P.H. Wu, S.K. Lin, Simvastatin alleviates the progression of periapical lesions by modulating autophagy and apoptosis in osteoblasts. J. Endod. 38, 757–763 (2012)CrossRefPubMed
12.
S. Ghavami, M.M. Mutawe, P. Sharma, B. Yeganeh, K.D. McNeill, T. Klonisch, H. Unruh, H.H. Kashani, D. Schaafsma, M. Los, A.J. Halayko, Mevalonate cascade regulation of airway mesenchymal cell autophagy and apoptosis: a dual role for p53. PLoS One 6, e16523 (2011)CrossRefPubMedPubMedCentral
Metadata
Title
Statin reduces orbitopathy risk in patients with Graves’ disease by modulating apoptosis and autophagy activities
Authors
Maurizio Bifulco
Elena Ciaglia
Publication date
01-09-2016
Publisher
Springer US
Published in
Endocrine / Issue 3/2016
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-015-0762-z

Other articles of this Issue 3/2016

Endocrine 3/2016 Go to the issue

Endocrine Imaging

Interventricular septum metastasis in neuroendocrine tumour

Meta-Analysis

Risk factors of gestational diabetes mellitus recurrence: a meta-analysis

Erratum

Erratum to: PI3K/Akt/mTOR signaling in medullary thyroid cancer: a promising molecular target for cancer therapy

Original Article

Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using 18F-FDG positron emission tomography

Original Article

Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer

Original Article

Brain metabolite abnormalities in ventromedial prefrontal cortex are related to duration of hypercortisolism and anxiety in patients with Cushing’s syndrome

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits